Cargando…
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
Autores principales: | Pabon, Cindy M., Li, Zhiguo, Hennig, Therese, de Castro, Carlos, Neff, Jadee L., Horwitz, Mitchell E., LeBlanc, Thomas W., Long, Gwynn D., Lopez, Richard D., Sung, Anthony D., Chao, Nelson, Gasparetto, Cristina, Sarantopoulos, Stefanie, Adams, Donna B., Erba, Harry, Rizzieri, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126559/ https://www.ncbi.nlm.nih.gov/pubmed/33994546 http://dx.doi.org/10.1038/s41408-021-00481-9 |
Ejemplares similares
-
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
por: Kanda, Junya, et al.
Publicado: (2011) -
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
por: Green, Michael M. B., et al.
Publicado: (2016) -
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
por: Smith, Patrick J., et al.
Publicado: (2022) -
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
por: Ramalingam, Sendhilnathan, et al.
Publicado: (2021) -
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
por: Pagliuca, Simona, et al.
Publicado: (2023)